Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in the TSPEAR gene cause a new form of ectodermal dysplasia affecting hair and tooth development.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Mouse high-glycine/tyrosine proteins have distinct patterns in hair follicles, peaking at specific hair cycle days.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Pmg-1 and Pmg-2 are new genes important for skin and mammary gland development.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Different mutations in the 5 alpha-reductase-2 gene were found in affected individuals in the Dominican Republic, suggesting no common ancestry.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

Two specific SNPs in the TRPS1 gene cause excessive hair growth by altering the protein's structure.

GPR40 agonists help hair growth through the protein ANGPTL4.

Hair loss gene linked to prostate issues.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

Mutations in the PTPRQ gene cause significant balance issues in mice due to hair bundle defects in the inner ear.

cgVEGF164 boosts hair follicle growth in mice.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Deleting Gpr54 speeds up hair growth and regeneration.

Mutations in the P2RY5 gene cause autosomal recessive woolly hair.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Deleting the PTEN gene in mice causes nerve cells to grow larger and heal better after injury, but may cause overgrowth and hair loss in older mice.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.